Skip Navigation
Menu
Editorials |1 September 1993

Nosocomial Outbreaks of Multiresistant Bacteria: Extended-Spectrum Beta-Lactamases Have Arrived in North America

Antone A. Medeiros, MD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
Copyright 2004 by the American College of Physicians
2004
  • The Miriam Hospital, Providence, RI 02906. Requests for Reprints: Antone A. Medeiros, MD, The Miriam Hospital, 164 Summit Avenue, Providence, RI 02906.
×
FULL TEXT
The history of the antibiotic era shows that widespread use of new antibiotics fosters emergence of resistant clinical isolates, often possessing novel antimicrobial resistance mechanisms. Clinical use of oxyimino--lactams, particularly ceftazidime and cefotaxime, skyrocketed during the last 15 years. In 1983 plasmid-mediated enzymes that confer resistance to oxyimino--lactamsextended-spectrum -lactamases (ESBL)were first observed in Germany. Since then, the number and variety of these -lactamases have increased rapidly and their distribution is now worldwide.
Most of the ESBLs derive from TEM-1 or 2 and SHV-1, the common plasmid-determined -lactamases that confer resistance to penicillins and early-generation cephalosporins. Substitution of a single amino acid in the active site region of the SHV-1 molecule transforms it into the extended-spectrum -lactamase, SHV-2, that can inactivate late-generation cephalosporins. The number of derivatives of the TEM and SHV -lactamases proven to be unique by sequencing or oligotyping has now reached 26 and 5, respectively [1, 2]. Several have been found in many countries (SHV-2, SHV-4, SHV-5, TEM-6), whereas others seem to occur more commonly in one or two countries. For example, TEM-3 seems more prevalent in France and TEM-10 and TEM-12 in the United States and England [1]. Most of the isolates that produce ESBLs have come from hospitalized patients and have frequently caused nosocomial outbreaks, primarily due to Klebsiella pneumoniae strains that often have associated resistance to aminoglycosides. Recent surveys of nosocomial isolates of K. pneumoniae from Europe show that 14% to 16% produce ESBLs [3, 4]. In France the prevalence increased from less than 1% in 1985 to the current level by 1988. Extended-spectrum -lactamases are found much less frequently in other species of Enterobacteriaceae [3, 4].
FULL TEXT
PDF
Not Available
Citations
Citation

Medeiros AA. Nosocomial Outbreaks of Multiresistant Bacteria: Extended-Spectrum Beta-Lactamases Have Arrived in North America. Ann Intern Med. ;119:428–430. doi: 10.7326/0003-4819-119-5-199309010-00015

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 1993;119(5):428-430.

DOI: 10.7326/0003-4819-119-5-199309010-00015

41 Citations

Related Articles
Epizootic Outbreak of Yellow Fever Virus and Risk for Human Disease in Salvador, Brazil
Annals of Internal Medicine; 168 (4): 301-302
What Recent History Has Taught Us About Responding to Emerging Infectious Disease Threats
Annals of Internal Medicine; 167 (11): 805-811
Ebola Hemorrhagic Fever in 2014: The Tale of an Evolving Epidemic
Annals of Internal Medicine; 161 (10): 746-748
Ready or Not: Responding to Measles in the Postelimination Era
Annals of Internal Medicine; 161 (2): 145-146
View MoreView Less

Related Topics
Infectious Disease

Infectious Disease.

PubMed Articles
Structural and functional characterization of a frataxin from a thermophilic organism.
FEBS J 2019.
Seasonal patterns and space-time clustering of porcine reproductive and respiratory syndrome (PRRS) cases from 2008 to 2016 in Vietnam.
Transbound Emerg Dis 2019.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×